Citation tools
"Antibodies Against Mutated Citrullinated Vimentin Are a Better Predictor of Disease Activity at 24 Months in Early Rheumatoid Arthritis Than Antibodies Against Cyclic Citrullinated Peptides." The Journal of Rheumatology
35.6
(2008):
1002-1008.
Web. 22 April. 2024.